Abstract
Glutathione (GSH)/light dual-responsive supramolecular drug carriers (abbreviated as CPAP) based on CD-PEG⊃Azo-PCL were fabricated for intracellular delivery of doxorubicin (DOX). The carriers were spherical with a diameter of 70–90 nm and exhibited GSH/light sensitivity. The GSH response attributed to disulfide bonds between PEG and β-cyclodextrin (β-CD), and the light response was achieved by a simple host-guest interaction between β-CD and azobenzene. DOX was encapsulated into the hydrophobic core of CPAP. The drug loaded CPAP (CPAP@DOX) displayed the fastest drug release in the presence of GSH and light simultaneously. The cytotoxicities of CPAP and CPAP@DOX were explored by SKOV3 cells and HEK293T cells. The results of cell experiments indicated that CPAP@DOX could effectively inhibit cancer cells while had reduced toxicity to normal cells. We believe that CPAP@DOX drug delivery system may present promising application for precisely controllable drug release.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
